Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 01)
Topiramate Tablet, Film Coated
Product Images NDC 50090-5853
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-5853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structured Product Formula For Topiramate (7ea951b6 B020 481f 8acc 12fb7a3a69fd 02)
The text provides cumulative rates for time to first seizure for Topiramate at 50 mg/day and 400 mg/day, with a significant difference in P value of 0.0002. The graph shows time (in days) on the x-axis and values ranging from 0 to 400 on the y-axis.*
Topiramate Tablets Usp (7ea951b6 B020 481f 8acc 12fb7a3a69fd 03)
This is a table that shows the change in average monthly migraine period rates from baseline to the double-blind phase in patients receiving topiramate at different doses and placebo. The table includes the number of participants in each group, denoted by 'N', and shows a statistically significant difference between the topiramate treatments and placebo.*
Label Image (Lbl500905853)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
